Compare CAPR & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAPR | GCBC |
|---|---|---|
| Founded | 2005 | 1889 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 569.0M |
| IPO Year | 2011 | 1998 |
| Metric | CAPR | GCBC |
|---|---|---|
| Price | $6.71 | $34.32 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $27.00 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 30.8K |
| Earning Date | 11-09-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | N/A | ★ 31.69 |
| EPS | N/A | ★ 2.41 |
| Revenue | N/A | ★ $4,117,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.52 | N/A |
| P/E Ratio | ★ N/A | $14.21 |
| Revenue Growth | N/A | ★ 11.06 |
| 52 Week Low | $2.96 | $21.38 |
| 52 Week High | $40.37 | $36.33 |
| Indicator | CAPR | GCBC |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 49.25 |
| Support Level | $6.01 | $34.05 |
| Resistance Level | $10.12 | $35.84 |
| Average True Range (ATR) | 0.53 | 0.63 |
| MACD | -0.15 | 0.01 |
| Stochastic Oscillator | 9.03 | 76.19 |
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.